Annual Shareholders Equity
$6.53 B
+$898.35 M+15.96%
31 December 2023
Summary:
Royalty Pharma annual stockholders equity is currently $6.53 billion, with the most recent change of +$898.35 million (+15.96%) on 31 December 2023. During the last 3 years, it has risen by +$1.71 billion (+35.44%). RPRX annual shareholders equity is now at all-time high.RPRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$6.87 B
+$393.63 M+6.08%
30 September 2024
Summary:
Royalty Pharma quarterly stockholders equity is currently $6.87 billion, with the most recent change of +$393.63 million (+6.08%) on 30 September 2024. Over the past year, it has increased by +$730.96 million (+11.91%). RPRX quarterly shareholders equity is now at all-time high.RPRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.0% | +11.9% |
| 3 y3 years | +35.4% | +18.6% |
| 5 y5 years | +45.4% | - |
RPRX Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +35.4% | at high | +22.1% |
| 5 y | 5 years | at high | +45.4% | at high | +65.3% |
| alltime | all time | at high | +45.4% | at high | +65.3% |
Royalty Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.87 B(+6.1%) |
| June 2024 | - | $6.48 B(-0.4%) |
| Mar 2024 | - | $6.50 B(-0.4%) |
| Dec 2023 | $6.53 B(+16.0%) | $6.53 B(+6.3%) |
| Sept 2023 | - | $6.14 B(-2.3%) |
| June 2023 | - | $6.28 B(+5.5%) |
| Mar 2023 | - | $5.95 B(+5.8%) |
| Dec 2022 | $5.63 B | $5.63 B(-8.5%) |
| Sept 2022 | - | $6.15 B(+2.1%) |
| June 2022 | - | $6.03 B(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $5.78 B(+0.0%) |
| Dec 2021 | $5.78 B(+19.9%) | $5.78 B(-0.3%) |
| Sept 2021 | - | $5.79 B(+1.0%) |
| June 2021 | - | $5.73 B(+17.4%) |
| Mar 2021 | - | $4.88 B(+1.3%) |
| Dec 2020 | $4.82 B(-21.1%) | $4.82 B(+8.2%) |
| Sept 2020 | - | $4.45 B(+7.1%) |
| June 2020 | - | $4.16 B(-19.4%) |
| Mar 2020 | - | $5.16 B(-15.5%) |
| Dec 2019 | $6.11 B(+36.0%) | $6.11 B |
| Dec 2018 | $4.49 B | - |
FAQ
- What is Royalty Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Royalty Pharma?
- What is Royalty Pharma annual shareholders equity year-on-year change?
- What is Royalty Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Royalty Pharma?
- What is Royalty Pharma quarterly shareholders equity year-on-year change?
What is Royalty Pharma annual stockholders equity?
The current annual shareholders equity of RPRX is $6.53 B
What is the all time high annual shareholders equity for Royalty Pharma?
Royalty Pharma all-time high annual stockholders equity is $6.53 B
What is Royalty Pharma annual shareholders equity year-on-year change?
Over the past year, RPRX annual stockholders equity has changed by +$898.35 M (+15.96%)
What is Royalty Pharma quarterly stockholders equity?
The current quarterly shareholders equity of RPRX is $6.87 B
What is the all time high quarterly shareholders equity for Royalty Pharma?
Royalty Pharma all-time high quarterly stockholders equity is $6.87 B
What is Royalty Pharma quarterly shareholders equity year-on-year change?
Over the past year, RPRX quarterly stockholders equity has changed by +$730.96 M (+11.91%)